SLGL

Sol-Gel Technologies Ltd. - Common Stock (SLGL)

About Sol-Gel Technologies Ltd. - Common Stock (SLGL)

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.

Details

Daily high

$8.40

Daily low

$8.02

Price at open

$8.08

52 Week High

$16.50

52 Week Low

$3.34

Market cap

22.6M

Dividend yield

0.00%

Volume

4,501

Avg. volume

6,007

P/E ratio

-1.74

Sol-Gel Technologies Ltd. - Common Stock News